The internet was in its infancy when we were founded 21 years ago. People diagnosed with an MPN now had a place to go to look for information. But there was little to learn once they got there. Meaningful research was scarce.
Check out our IMPACT@21 story in this new digital report, featuring the voices of leading MPN researchers, clinicians, advocates and patients.
Born of necessity. Raised by determination. Driven to mind the gap. We're proud of where we started, where we are, and where we're going. Our entrepreneurial attitude forced us outside the box from day one and that continues to drive our unique impact − on MPN research, clinical treatments, drug development, and most importantly, MPN patients.
What does that mean in practice? It means we don't just fund promising research. We look at critical gaps in current research that may move answers from the laboratory to the clinic, faster.
We play a uniquely independent role in the growing MPN community, convening academia, industry, patients, advocates and regulatory agencies, all to improve the lives of people living with essential thrombocythemia, polycythemia vera and myelofibrosis.
Read our story. Watch the videos. Engage in the impact.
IMPACT@21
